Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|March 30, 2019
Swiss-Meds: An App Fostering Medication Adherence of Swiss PatientFrederic Ehrler, Liliane Gschwind, Philippe Meyer, et al.
Revue Medicale Suisse|March 12, 2010
[Introduction of acenocoumarol using an algorithm for prescription]Grigorios Notaridis, Liliane Gschwind, Philippe de Moerloose, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
SMART-MEDS: Development of a Medication Adherence App for Acute Coronary Syndrome Patients based on a Gamified Behaviour Change ModelFrederic Ehrler, Liliane Gschwind, Philippe Meyer, et al.
JMIR Cardio|January 26, 2025
A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods StudyFrederic Ehrler, Liliane Gschwind, Hamdi Hagberg, et al.
Basic & Clinical Pharmacology & Toxicology|May 14, 2013
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell modelLiliane Gschwind, Victoria Rollason, Youssef Daali, et al.
Pharmacy (Basel, Switzerland)|June 25, 2025
The Medication Safety Adventure Trail: An Educational Intervention to Promote Public Awareness on Medication SafetyAudrey Flornoy-Guédon, Liliane Gschwind, Antoine Poncet, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 10, 2023
Development and evaluation of a blended learning training programme for pharmacy technicians' continuing educationAudrey Flornoy-Guédon, Caroline Fonzo-Christe, Emy Meier, et al.
JMIR Formative Research|January 15, 2025
Cardiomeds, an mHealth App for Self-Management to Support Swiss Patients With Heart Failure: 2-Stage Mixed Methods Usability StudyLisa Simioni, Elena Tessitore, Hamdi Hagberg, et al.
Pharmacogenomics|January 24, 2015
P-glycoprotein: a clue to vitamin K antagonist stabilizationLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Pharmacogenomics|May 9, 2013
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Pageof 2